MarketResearch.biz delivers in-depth insights on the global in vitro fertilization market in its upcoming report titled, “Global in vitro fertilization market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global in vitro fertilization market is estimated to register a X.X % in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global aids market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global in vitro fertilization market report has been segmented on the basis of product, technology, end user and region.
In vitro or in glass fertilization is a process of fertilization in which egg (ova) from a woman's ovary is removed and fertilized by combining it with sperm in a laboratory. Then the fertilized egg (zygote) is transferred to the same or another woman's uterus after undergoing embryo culture for a week with an intention of establishing successful pregnancy.
IVF is one of various assisted reproductive techniques (ART) used to treat infertile couples who cannot conceive even after one year of sexual intercourse without the use of birth control. Some of the reasons for infertility are hormonal imbalance, endometriosis or damaged or blocked fallopian tubes in females. and low sperm count or poor-quality sperm in males. IVF will not work for a woman who is not capable of ovulating or a man who is not able to produce at least a few healthy sperm. However, IVF should be considered as last option. If there are other possible treatments for these conditions, such as surgery for blocked tubes or endometriosis, it may be tried before starting in vitro fertilization process.
Rising rate of infertility, rising health care expenditure, growing awareness about infertility, and easy accessibility of IVF treatments, and technological advancements such has capsule IVF and embryoscope, insurance coverage for IVF are major factors driving growth of the global in vitro fertilization market. In addition, lifestyle changes, stressful and late-night working hours, improper food habits, rise in alcohol consumption, and late family planning are projected to propel growth of the global in vitro fertilization market. However, risk of failure associated with IVF cycles, emotional and physical stress due to disappointment, and financial burden are factors likely to restrain the global in vitro fertilization market.
Restrictions on availability of IVF, stringent regulations or high cost for in vitro fertilization treatment has given rise to fertility tourism. Medical tourism is providing an excellent opportunity for the growth of this market in many developing countries. In addition, rising awareness has led to increase in egg donation.
Europe accounts for largest market share of XX.X% of global in-vitro fertilization market owing to rising adoption in vitro babies among population. Asia Pacific market is expected to witness highest growth rate during the forecast period owing to high maternal age, abolishment of China’s one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS (polycystic ovarian syndrome) in countries in Asia Pacific.
In Vitro Fertilization, by Technology
- Intra-cytoplasmic Sperm Injection (ICSI)
- Pre-implantation Genetic Diagnosis (PGD)
- Frozen Embryo Transfer/ Replacement (FER)
- Others (Assisted hatching, intrauterine insemination, donor insemination and in vitro maturation)
Global in vitro fertilization market segmentation, by Product
Global in vitro fertilization market segmentation, by End User
- Fertility and Surgical Centers
- Hospitals and Research laboratories
Global in vitro fertilization market segmentation, by Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2016 Estimated Year 2017 Forecast Period 2017–2026 Revenue in US$
- CooperSurgical Inc.
- Vitrolife AB
- Cook Medical Inc.
- Irvine Scientific
- Thermo Fisher Scientific Inc.
- ESCO Micro Pte. Ltd.
- Genea Limited
- The Baker Company
- IVFtech ApS
- EMD Serono Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!